IRON Drug Patent Profile
✉ Email this page to a colleague
When do Iron patents expire, and what generic alternatives are available?
Iron is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in IRON is ferric oxyhydroxide. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ferric oxyhydroxide profile page.
AI Research Assistant
Sample questions
- What is the 5 year forecast for IRON?
- What are the global sales for IRON?
- What is Average Wholesale Price for IRON?
Summary for IRON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for IRON |
| Drug Sales Revenues: | Drug sales revenues for IRON |
| DailyMed Link: | IRON at DailyMed |
US Patents and Regulatory Information for IRON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | IRON DEXTRAN | ferric oxyhydroxide | INJECTABLE;INJECTION | 010787-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
